Table 1.
Author, y | Location | Study Design | Follow‐up, y | Sample Size | Age at Baseline, y | Male (%) | Events | Outcome Assessment | Study Quality |
---|---|---|---|---|---|---|---|---|---|
Kamei et al, 20169 | Japan | Prospective cohort | 2 | 155 322 | 40 to 73 | 39 | Nonfatal stroke: 1089 (M), 992 (W) | Self‐reporting questionnaire | 6 |
Jimenez et al, 201620 | United States | Nested case‐control | 17 | 920 | 30 to 55 | 0 | Ischemic stroke: 460 (W) | Medical records | 7 |
Zhang et al, 201610 | Japan | Prospective cohort | 10 | 36 313 | 35 to 89 | 43 | Fatal stroke: 301 (M), 293 (W) | ICD‐9 and ICD 10 | 8 |
Storhaug et al, 201315 | Norway | Prospective cohort | 12.5 | 5700 | ≥25 | 42 | Ischemic stroke: 430 | Hospital or out‐hospital records | 7 |
Holme et al, 200916 | Sweden | Prospective cohort | 11.8 | 417 734 | 30 to 85 | 53 | Stroke: 9324 (M), 6952 (W) | ICD‐7, ICD‐8, ICD‐9, ICD‐10 | 7 |
Strasak et al, 200817 | Austria | Prospective cohort | 15.2 | 28 613 | Mean 62.3 | 0 | Fatal stroke: 776 (W) | ICD‐9 and ICD‐10 | 9 |
Strasak et al, 200818 | Austria | Prospective cohort | 13.6 | 83 683 | Mean 41.6 | 100 | Fatal stroke: 645 (M) | ICD‐9 and ICD‐10 | 9 |
Hozawa et al, 200621 | United States | Prospective cohort | 12.6 | 11 263 | 45 to 64 | 46 | Ischemic stroke: 149 (M), 118 (W) | ICD‐9 | 8 |
Bos et al, 200619 | Netherlands | Prospective cohort | 8.4 | 4385 | ≥55 | 35.4 | All stroke: 132 (M), 249 (W) | Hospital records | 6 |
Chien et al, 200511 | Taiwan | Prospective cohort | 11 | 3602 | >35 | 47 | Stroke: 155 | Preliminary diagnoses, death certificates | 7 |
Gerber et al, 200612 | Israel | Prospective cohort | 23 | 9125 | ≥40 | 100 | Fatal stroke: 292 (M) | ICD‐9 | 6 |
Jee et al, 200413 | Korea | Prospective cohort | 9 | 22 698 | 30 to 77 | 100 | Fatal stroke: 192 (M) | Death certificate | 7 |
Sakata et al, 200114 | Japan | Prospective cohort | 14 | 8172 | ≥30 | 44 | Fatal stroke: 94 (M), 80 (W) | ICD‐9 | 9 |
ICD indicates International Classification of Diseases.